Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 3/20 | 0.45 |
| ▸ | CNR2 | P34972 | 2/20 | 0.45 |
| ▸ | SLC37A4 | O43826 | 1/20 | 0.45 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.43 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4142263 | 1.00 | PPARA (0.48) | PPARACNR1CNR2SLC37A4PLK1 | |
| SCHEMBL4142799 | 0.81 | PPARA (0.67) | PPARAHDAC1HDAC6 | |
| SCHEMBL28658973 | 0.81 | CNR1 (0.47) | CNR1CNR2SLC37A4FAAHEPHX2 | |
| SCHEMBL4142804 | 0.81 | PPARA (0.67) | PPARAHDAC1HDAC6 | |
| SCHEMBL28658975 | 0.81 | CNR1 (0.47) | CNR1CNR2SLC37A4FAAHEPHX2 | |
| SCHEMBL30987604 | 0.80 | ALOX5 (0.52) | SLC37A4HTR1ACYSLTR2CYSLTR1 | |
| SCHEMBL29141103 | 0.79 | CYSLTR2 (0.49) | CNR1CNR2CYSLTR2CYSLTR1FAAH | |
| SCHEMBL9508803 | 0.79 | CYSLTR2 (0.49) | CNR1CNR2CYSLTR2CYSLTR1FAAH | |
| SCHEMBL9508795 | 0.79 | CYSLTR2 (0.49) | CNR1CNR2CYSLTR2CYSLTR1FAAH | |
| SCHEMBL11045083 | 0.79 | NFE2L2 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090068126-A1 | Composition for surface photoprotection | SOARES ROMEIRO LUIZ ANTONIO | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068126-A1 | Composition for surface photoprotection | S100A10, CD63, S100A9 | PPARA 1792/4885CNR1 950/4885CNR2 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.